Header cover image

French (CAC) Healthcare Sector Analysis

UpdatedOct 30, 2023
DataAggregated Company Financials
Companies71
  • 7D-8.2%
  • 3M-16.1%
  • 1Y-8.9%
  • YTD-12.2%

Over the last 7 days, the Healthcare industry has dropped 8.2%, driven by a pullback from Sanofi of 18%. However, the industry is down 8.9% over the past year. As for the next few years, earnings are expected to grow by 12% per annum.

Sector Valuation and Performance

Has the French Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 30 Oct 2023€234.5b€104.2b€12.8b20.8x18.3x2.2x
Wed, 27 Sep 2023€269.6b€105.0b€12.5b21x21.6x2.6x
Fri, 25 Aug 2023€272.2b€104.5b€12.5b22.1x21.8x2.6x
Sun, 23 Jul 2023€275.6b€103.6b€12.3b19.5x22.3x2.7x
Tue, 20 Jun 2023€262.9b€103.8b€12.4b19.9x21.2x2.5x
Thu, 18 May 2023€276.2b€108.3b€12.1b20.9x22.9x2.6x
Sat, 15 Apr 2023€279.4b€107.8b€12.3b20.4x22.7x2.6x
Mon, 13 Mar 2023€258.4b€107.8b€12.7b19.6x20.4x2.4x
Wed, 08 Feb 2023€268.1b€105.9b€10.8b18.5x24.8x2.5x
Fri, 06 Jan 2023€266.4b€104.9b€10.5b17.5x25.4x2.5x
Sun, 04 Dec 2022€269.2b€105.1b€10.5b18.6x25.7x2.6x
Tue, 01 Nov 2022€257.2b€104.9b€10.2b17.7x25.2x2.5x
Thu, 29 Sep 2022€172.7b€79.3b€9.0b16.1x19.3x2.2x
Sat, 27 Aug 2022€191.5b€78.9b€9.0b20.6x21.2x2.4x
Mon, 25 Jul 2022€212.6b€76.7b€9.1b20.6x23.2x2.8x
Wed, 22 Jun 2022€194.3b€76.4b€9.2b18.2x21.1x2.5x
Fri, 20 May 2022€208.8b€75.5b€9.2b19.1x22.7x2.8x
Sun, 17 Apr 2022€220.7b€74.4b€8.8b19.6x25.1x3x
Tue, 15 Mar 2022€203.4b€73.7b€8.5b18.8x23.8x2.8x
Thu, 10 Feb 2022€210.8b€72.4b€8.6b18.9x24.6x2.9x
Sat, 08 Jan 2022€216.9b€71.8b€8.5b23x25.5x3x
Mon, 06 Dec 2021€218.3b€71.8b€8.5b22.2x25.7x3x
Wed, 03 Nov 2021€228.5b€71.7b€8.5b24.4x26.9x3.2x
Fri, 01 Oct 2021€218.0b€70.5b€8.0b22.7x27.1x3.1x
Sun, 29 Aug 2021€230.4b€70.2b€8.1b26.1x28.5x3.3x
Mon, 05 Jul 2021€212.5b€70.2b€8.1b26.6x26.3x3x
Thu, 08 Apr 2021€199.0b€68.5b€14.2b28.3x14x2.9x
Sun, 10 Jan 2021€185.4b€67.9b€14.0b28.1x13.2x2.7x
Price to Earnings Ratio

14.9x


Total Market Cap: €183.7bTotal Earnings: €12.3bTotal Revenue: €67.2bTotal Market Cap vs Earnings and Revenue0%0%0%
French Healthcare Sector Price to Earnings3Y Average 21.8x202120222023
Current Industry PE
  • Investors are pessimistic on the French Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 19.0x which is lower than its 3-year average PE of 21.8x.
  • The 3-year average PS ratio of 2.8x is higher than the industry's current PS ratio of 2.2x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 16% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the French Healthcare sector?

FR Market0.10%
Healthcare-8.15%
Healthtech4.96%
Medical Equipment2.90%
Biotech1.43%
Life Sciences-4.53%
Healthcare Services-7.96%
Pharma-15.96%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry, which is trading close to its 3-year average PE ratio of 32.3x.
    • Analysts are expecting annual earnings growth of 12.8%, which is higher than its past year's earnings growth of 1.1% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 20% over the next 5 years.
  • This is better than its past earnings decline of 32% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 10% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EL EssilorLuxottica Société anonyme€168.021.5%
+€1.1b
4.8%PE32.3x
VIRP Virbac€270.006.5%
+€139.3m
8.9%PE19.1x
BIM bioMérieux€88.521.3%
+€134.7m
-1.1%PE27.1x
EQS Equasens Société anonyme€68.807.8%
+€75.2m
-3.2%PE21.3x
ALSEN Sensorion€0.6124.9%
+€22.8m
22.4%PS20.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

VETO

€78.80

Vetoquinol

7D

-1.6%

1Y

-6.3%

SAN

€81.44

Sanofi

7D

-17.2%

1Y

-6.7%

IPN

€110.90

Ipsen

7D

-3.3%

1Y

6.6%

MAAT

€7.02

MaaT Pharma

7D

15.1%

1Y

-19.3%

EL

€168.02

EssilorLuxottica Société anonyme

7D

1.5%

1Y

4.8%

CLARI

€3.71

Clariane

7D

-27.0%

1Y

-61.2%

DIM

€165.55

Sartorius Stedim Biotech

7D

-4.5%

1Y

-48.5%

ABVX

€8.78

ABIVAX Société Anonyme

7D

9.8%

1Y

21.9%

ALSEN

€0.61

Sensorion

7D

24.9%

1Y

22.4%

IVA

€3.51

Inventiva

7D

3.8%

1Y

-25.5%

AFME

€1.24

Affluent Medical

7D

17.0%

1Y

-29.5%